CIK 0001430306
- Non-accelerated filer
- Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 261434750
- Phone
- +1 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 5,300 shares at $3.61 ($19,133)
- 4 Open-market sale Director sold 36,967 shares at an average $3.51 ($129,814)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at an average $3.00 ($60,018)
- 4 Open-market sale Director sold 6,105 shares at $4.28 ($26,117)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.33 ($21,640)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.40 ($22,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $4.22 ($84,400)
- 4 Derivatives Options or other derivatives
Page 10 of 19 · 376 filings